About Us

About Us

Aditri is a Contract Development and Manufacturing Organization (CDMO) focused on the infectious diseases segment. Our product portfolio includes the manufacturing of select APIs as well as finished dosages for HIV and TB combination drugs..

Official Company Profile

Built for niche pharmaceutical development with a global outlook.

Aditri Pharma Sciences Private Limited is an envisioned pharmaceutical company engaged in the collaborative development and manufacturing of niche pharmaceutical products for the generic industry. Our team of professionals, each with over three decades of reliable experience, is at the helm of innovation in the manufacturing of finished formulations and select active pharmaceutical ingredients.

Aditri Pharma Sciences

The Aditri Standard

Built on experience. Moving with purpose.

The principles that shape how Aditri develops products, works with partners, and serves global markets.

Where we are going

Our Vision

To deliver innovative pharmaceutical products and services that enhance patient lives worldwide through our expertise in contract research and development, complemented by innovative business development strategies. Through strategic partnerships and cutting-edge manufacturing capabilities, we aim to address critical healthcare needs in underserved markets, particularly for HIV and TB treatments where access to affordable medication remains crucial.

Our standards

Quality

We deliver outstanding products and unsurpassed service that together provide premium value to our customers. Each formulation meets or exceeds the highest international standards.

Our standards

Integrity & Compliance

We uphold the highest standards in all our actions, ensuring transparent operations, ethical business practices, and strict adherence to regulatory requirements across global markets.

Aditri Pharma Sciences

Established Experience

A focused pharmaceutical company with the depth and discipline to move niche products from development into dependable global supply.

  • Founded in 2019 with 30+ years of management experience
  • Expertise from Big Pharma and MNC companies
  • Operating on the CDMO (Contract Development and Manufacturing Organization) model
Our standards

Teamwork

We collaborate across boundaries to meet customer needs, leveraging diverse expertise and perspectives to develop innovative pharmaceutical solutions that address complex health challenges.

Our standards

Mutual Respect

We value people and their contributions, fostering an environment of mutual respect that encourages participation and rewards performance excellence at all levels of our organization.

Our standards

Will to Win

We exhibit a strong determination to win customer confidence through product quality and service excellence, prioritizing mutual benefits in every aspect of our business relationships.

Management Team

Experience across pharma, supply chain, and regulated markets.

Scroll to move through the story.

CEO & Managing Director

Gopi Krishnan Shivraj

  • Holds Masters Degree in Business Management
  • 30+ years of progressive experience in strategic business development in the pharmaceutical industry at Big Pharma companies including Lupin, Alembic, and Mylan.
  • Leads operations and strategic direction for a startup company with full responsibility for long-range planning and identifying products for global markets.

Executive Director

Krishna Priya Dantuluri

  • Holds Masters degree in Management
  • 25 years of experience in the pharmaceutical industry, including work with Mylan Laboratories Ltd.
  • Heads regulatory and compliance, initiates strategic planning across pharmaceutical manufacturing, and supports the launch of new products for regulated markets.
  • Leads seamless conversion of developed processes to commercial manufacturing and compliance across CDMO sites.

Executive Director

Vijay Kumar Kumpatla

  • Holds Bachelors degree in Arts
  • Pharma veteran with over 30 years of experience in business development, supply chain management, PPIC, and procurement of RMs with Matrix Laboratories / Mylan Laboratories Ltd.
  • Heads supply chain management and sourcing of raw material, excipients, packing material, and strategic planning for future growth.

Chief Financial Officer

Dilip Kumar Pothina

  • Holds a Master of Commerce and is a Cost and Management Accountant (CMA), an Associate Member of the Institute of Cost Accountants of India.
  • 30+ years’ experience across Corporate Finance, FP&A, Financial Reporting, Treasury, Taxation, Manufacturing Finance, Product Costing, M&A and SAP-led business transformation.
  • Led financial and tax due diligence for a successful private-equity acquisition.

Business Development

G. Aditya Krishnan

  • B.Tech (Computer Sciences Engineering), JNTU
  • Alumnus of Indian School of Business (ISB), Hyderabad
  • Core management group for strategy planning and business development with clients across the globe. Part of succession planning for the next generation.
Aditri has been successfully audited by WHO-PQ in July 2026.Aditri holds the Market Authorization (MA) for Finished Dosages and select APIs.Aditri has been successfully audited by WHO-PQ in July 2026.Aditri holds the Market Authorization (MA) for Finished Dosages and select APIs.
✦ API - WHO-PQ✦ Dosages - USFDA✦ WHO-Geneva✦ MHRA✦ SAPHRA✦ EU GMP✦ BA/BE - USFDA✦ MHRA/EU GMP✦ API - WHO-PQ✦ Dosages - USFDA✦ WHO-Geneva✦ MHRA✦ SAPHRA✦ EU GMP✦ BA/BE - USFDA✦ MHRA/EU GMP